TechCare: Mobile-AssessmenT and ThErapy for PsyCHosis: An Intervention for Clients Within the EArly InteRvention SErvice (TechCare)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02439619|
Recruitment Status : Unknown
Verified May 2015 by Lancashire Care NHS Foundation Trust.
Recruitment status was: Recruiting
First Posted : May 12, 2015
Last Update Posted : May 12, 2015
|Condition or disease||Intervention/treatment||Phase|
|Feasibility Studies||Other: TechCare||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||16 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||TechCare: Mobile-AssessmenT and ThErapy for PsyCHosis: An Intervention for Clients Within the EArly InteRvention SErvice|
|Study Start Date :||October 2014|
|Estimated Primary Completion Date :||September 2016|
|Estimated Study Completion Date :||September 2017|
|Experimental: Feasibility Trial||
The TechCare software is being developed specifically for use on a touch screen mobile phone. The mobile application will alert participants through notifications and ask a number of questions. Based on participant responses the app will provide a CBT based response to individuals or the service users preferred multimedia such as music, images and videos.
- Feasibility and Acceptability [ Time Frame: 36 months ]We will measure feasibility and acceptability by exploring whether appropriate individuals can be identified and recruited to an open trial of TechCare; whether TechCare is an acceptable intervention for individuals with psychosis and what measures will be important for assessing the impact of TechCare on delusions and low mood in psychosis.
- Psychopathology on The Positive and Negative Syndrome Scale (PANSS) [ Time Frame: 24 months ]The 30- item PANSS, is a clinician administered 30 item semi structured interview which provides balanced representation of positive symptoms and negative symptoms and gauges their relationship to one another and to global/general psychopathology
- Psychopathology on The Psychotic Symptom Rating Scales (PSYRATS) [ Time Frame: 24 months ]The PSYRATS is a semi-structured interview measuring dimensions of delusions and hallucinations.
- Satisfaction with CBT therapy on the CHoice of Outcome In Cbt for psychosEs [ Time Frame: 24 months ]This is an outcome measure which reflects the aims of cognitive behavioural therapy for psychosis and the priorities of service users.
- Mental wellbeing on the Warwick-Edinburgh Mental Well Being Scale (WEMWBS) [ Time Frame: 24 months ]The WEMWBS is a measure of mental wellbeing which focuses entirely on positive aspects of mental health.
- Measure of core beliefs regarding self and others on the Brief Core Schema Scale [ Time Frame: 24 months ]This is a 24 item measure of core beliefs regarding self and others. It is a nine item scale which allows for the quantitative and subjective dimension of depression in schizophrenia.
- Depression on the Calgary depression scale [ Time Frame: 24 months ]The CDS was developed to measure the level of depression in schizophrenia. It is a nine item scale which allows for the quantitative and subjective dimension of depression in schizophrenia.
- Work and social functioning on The Work and Social Adjustment Scale [ Time Frame: 24 months ]This is a five item measure of perceived impairment in five areas: work, home management, social life, private leisure and relationships
- Quality of life on the EuroQoL-5 Dimensions EQ5-D [ Time Frame: 24 months ]the measure is standardised instrument looking at quality of life across five health domains (mobility, self-care, usual activities, pain/discomfort and anxiety/depression).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02439619
|Contact: Charlotte Bee, PhD||01772 firstname.lastname@example.org|
|Contact: Nadeem Gire, BSc MScemail@example.com|
|Lancashire Care NHS Foundation Trust||Recruiting|
|Preston, Lancashire, United Kingdom, PR2 8DW|
|Contact: Charlotte Bee, PhD 01772 773498 firstname.lastname@example.org|
|Contact: Nadeem Gire, BSc MSc 07507847569 email@example.com|
|Principal Investigator: Imran B Chaudhry, MBBS MD|
|Principal Investigator: Nusrat Husain, MBBS MD|
|Principal Investigator: James Kelly, DClinPsych|
|Principal Investigator:||Imran B Chaudhry, MBBS MD||Lead Consultant Psychiatrist, Lancashire Care Early Intervention Service & Hon Clinical Professor Adult Psychiatry University of Manchester|
|Principal Investigator:||Nusrat Husain, MBBS MD||Reader in Psychiatry University of Manchester, Director Research Global Health Manchester Academic Health Sciences Centre & Consultant Psychiatrist Lancashire Care Early Intervention Service|
|Principal Investigator:||James Kelly, DClinPsych||Lancashire Care NHS Foundation Trust Early Intervention Service|